top of page

A New Patent for CNS

The United States Patent and Trademark Office has notified CNS that they will be issued a patent on December 27th, 2022, for several unique pharmaceuticals which we believe will be useful for treating neurodegenerative diseases.

Σχόλια


bottom of page